The Brain Tumor SPORE represents the translational research component of the Cancer Center’s Neurologic Oncology Program, which brings together neurosurgeons, neuro-oncologists, and basic scientists with the shared goal of improving the therapy of brain tumors. Learn more.
Administrator: Larissa Best
[email protected] | (415) 502-5047
The DHART SPORE represents the translational research component of the Cancer Center’s Pediatric Malignancies Program, which brings together basic and clinical researchers with the shared goal of improving the outcome for children with cancer. Learn more.
The Prostate Cancer SPORE, led by the Cancer Center's Prostate Cancer Program, aims to reduce the suffering and mortality associated with prostate cancer by leveraging a deep understanding of the disease to translate biological findings into clinical impact. Learn more.
In 1992, NCI established the Specialized Programs of Research Excellence (SPORE). The Translational Research Program (TRP) is the home of the SPOREs, a cornerstone of NCI’s efforts to promote collaborative, interdisciplinary translational cancer research. SPORE grants involve both basic and clinical/applied scientists, and support projects that will result in new and diverse approaches to the prevention, early detection, diagnosis, and treatment of human cancers. Each SPORE focuses on a specific organ site, such as breast or lung cancer, or on a group of highly related cancers, such as gastrointestinal cancers. SPOREs are designed to enable the rapid and efficient movement of basic scientific findings into clinical settings, as well as to determine the biological basis for observations made in individuals with cancer or in populations at risk for cancer.